BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31437796)

  • 1. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brucella antigens (BhuA, 7α-HSDH, FliC) in poly I:C adjuvant as potential vaccine candidates against brucellosis.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    J Immunol Methods; 2022 Jan; 500():113172. PubMed ID: 34673003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    Int J Nanomedicine; 2020; 15():3877-3886. PubMed ID: 32581535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
    J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S; Singh D; Gupta M; Bhatnagar R
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel recombinant multi-epitope protein against Brucella melitensis infection.
    Yin D; Li L; Song D; Liu Y; Ju W; Song X; Wang J; Pang B; Xu K; Li J
    Immunol Lett; 2016 Jul; 175():1-7. PubMed ID: 27133932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
    Sislema-Egas F; Céspedes S; Fernández P; Retamal-Díaz A; Sáez D; Oñate A
    Vaccine; 2012 Nov; 30(50):7286-91. PubMed ID: 23026687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.
    Wang Y; Wu A; Xu Z; Zhang H; Li H; Fu S; Liu Y; Cui L; Miao Y; Wang Y; Zhumanov K; Xu Y; Sheng J; Yi J; Chen C
    Int Immunopharmacol; 2024 Jan; 127():111351. PubMed ID: 38113688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
    Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV
    Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice.
    Zhang F; Li Z; Jia B; Zhu Y; Pang P; Zhang C; Ding J
    Sci Rep; 2019 Mar; 9(1):3512. PubMed ID: 30837598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.